STAAR Surgical Co Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
STAAR Surgical Co (STAA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $25.48 per share for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-04-03 was $18.46, a 20.26% increase year-over-year.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-28 was $15.35, a 58.75% decline year-over-year.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-29 was $37.21.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2026 was $18.22, a 51.81% decline from fiscal 2024.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $37.81, a 27.12% decline from fiscal 2023.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $51.88, a 29.42% decline from fiscal 2022.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $73.51, a 22.88% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-07-03 | $25.48 10-Q · filed 2026-08-12 | |||
| 2026-04-03 | $18.46 10-Q · filed 2026-05-13 | |||
| 2026-01-02 | $18.22 10-K · filed 2026-03-03 | |||
| 2025-09-26 | $18.22 10-Q · filed 2025-11-05 | |||
| 2025-06-27 | $17.53 10-Q · filed 2025-08-06 | |||
| 2025-03-28 | $15.35 10-Q · filed 2025-05-07 | |||
| 2024-12-27 | $37.81 10-K · filed 2025-02-21 | |||
| 2024-09-27 | $38.03 10-Q · filed 2024-10-30 | |||
| 2024-06-28 | $38.14 10-Q · filed 2024-08-07 | |||
| 2024-03-29 | $37.21 10-Q · filed 2024-05-07 | |||
| 2023-12-29 | $51.88 10-K · filed 2024-02-27 | |||
| 2023-09-29 | $55.84 10-Q · filed 2023-11-06 | |||
| 2022-12-30 | $73.51 10-K · filed 2023-02-23 | |||
| 2021-12-31 | $95.32 10-K · filed 2022-02-23 | |||
| 2021-01-01 | $28.78 10-K · filed 2021-02-24 | |||
| 2020-01-03 | $35.40 10-K · filed 2020-02-26 | |||
| 2018-12-28 | $23.19 10-K · filed 2019-02-21 | |||
| 2017-12-29 | $10.19 10-K · filed 2018-02-28 | |||
| 2016-12-30 | $7.32 10-K · filed 2017-03-02 | |||
| 2016-01-01 | $7.81 10-K · filed 2016-03-11 | |||
| 2015-01-02 | $15.43 10-K · filed 2015-03-13 | |||
| 2014-01-03 | $6.77 10-K · filed 2014-03-12 | |||
| 2012-12-28 | $10.31 10-K · filed 2013-03-12 | |||
| 2012-06-29 | $10.86 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |